Published in J Oral Maxillofac Surg on June 01, 1997
Antibacterial activity of a sterile antimicrobial polyisoprene surgical glove against transient flora following a 2-hours simulated use. BMC Surg (2015) 0.81
Percutaneous self-injury to the femoral region caused by bur breakage during surgical extraction of a patient's impacted third molar. J Korean Assoc Oral Maxillofac Surg (2015) 0.75
A novel wiring technique in mandibular condylar fracture: customised interdental wire hooks. Indian J Plast Surg (2015) 0.75
A technique for intraoperative maxillomandibular fixation. Oral Maxillofac Surg (2017) 0.75
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev (1998) 9.03
Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev (1999) 6.87
Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene (1991) 5.32
The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc Natl Acad Sci U S A (1993) 4.66
Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev (2000) 3.72
Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors. Immunity (2000) 3.06
Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction. Proc Natl Acad Sci U S A (1993) 2.88
Selective immortalization of murine macrophages from fresh bone marrow by a raf/myc recombinant murine retrovirus. Nature (1986) 2.64
p120, a novel substrate of protein tyrosine kinase receptors and of p60v-src, is related to cadherin-binding factors beta-catenin, plakoglobin and armadillo. Oncogene (1992) 2.49
Protein tyrosine phosphatase containing SH2 domains: characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13. Mol Cell Biol (1992) 2.41
Mutational activation of c-raf-1 and definition of the minimal transforming sequence. Mol Cell Biol (1990) 2.24
Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis. Mol Cell Biol (2001) 2.15
Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis. Mol Cell Biol (2001) 1.96
Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol Cell Biol (1995) 1.85
Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling. Nature (1991) 1.83
Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential. Mol Cell Biol (1991) 1.82
Pivotal role for the NFIL3/E4BP4 transcription factor in interleukin 3-mediated survival of pro-B lymphocytes. Proc Natl Acad Sci U S A (1997) 1.82
Epstein-barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma. Mol Cell Biol (1999) 1.80
c-Myc and apoptosis. Biochim Biophys Acta (1995) 1.80
Abrogation of IL-3 and IL-2 dependence by recombinant murine retroviruses expressing v-myc oncogenes. Nature (1985) 1.77
Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nat Med (1999) 1.71
The Max network gone mad. Mol Cell Biol (2001) 1.66
The ornithine decarboxylase gene is essential for cell survival during early murine development. Mol Cell Biol (2001) 1.65
Activation of c-myc gene expression by tumor-derived p53 mutants requires a discrete C-terminal domain. Mol Cell Biol (1998) 1.62
Inactivation of erythropoietin receptor function by point mutations in a region having homology with other cytokine receptors. Mol Cell Biol (1993) 1.62
Investigations of patients of health care workers infected with HIV. The Centers for Disease Control and Prevention database. Ann Intern Med (1995) 1.59
raf family serine/threonine protein kinases in mitogen signal transduction. Cold Spring Harb Symp Quant Biol (1988) 1.57
Transactivation of the c-myc promoter by human T cell leukemia virus type 1 tax is mediated by NF kappa B. J Biol Chem (1992) 1.56
Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis. Mol Cell Biol (1994) 1.55
Mammalian cells express two differently localized Bag-1 isoforms generated by alternative translation initiation. Biochem J (1997) 1.49
Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis. Genes Dev (2000) 1.47
Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis. J Virol (2000) 1.42
Fetal cleft lip repair in rabbits: histology and role of hyaluronic acid. J Oral Maxillofac Surg (1992) 1.41
Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1. Oncogene (1994) 1.40
Expression of raf family proto-oncogenes in normal mouse tissues. Oncogene (1990) 1.40
A pathway distinct from the mammalian unfolded protein response regulates expression of endoplasmic reticulum chaperones in non-stressed cells. EMBO J (1997) 1.38
Role of myc in the abrogation of IL3 dependence of myeloid FDC-P1 cells. Oncogene Res (1987) 1.38
Rapid induction of hemopoietic neoplasms in newborn mice by a raf(mil)/myc recombinant murine retrovirus. J Virol (1985) 1.35
Apoptosis-inducing factor mediates microglial and neuronal apoptosis caused by pneumococcus. J Infect Dis (2001) 1.30
The effect of mandibular third molar presence and position on the risk of an angle fracture. J Oral Maxillofac Surg (2000) 1.25
Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1. Oncogene (2001) 1.25
Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies. Genes Dev (1998) 1.24
E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis. Mol Cell Biol (1995) 1.20
PCTAIRE-1 and PCTAIRE-3, two members of a novel cdc2/CDC28-related protein kinase gene family. Oncogene (1992) 1.19
Identification of novel protein tyrosine phosphatases of hematopoietic cells by polymerase chain reaction amplification. Blood (1991) 1.18
Fluoride varnishes. A review of their clinical use, cariostatic mechanism, efficacy and safety. J Am Dent Assoc (2000) 1.17
Interaction between Raf and Myc oncogenes in transformation in vivo and in vitro. J Cell Biochem (1986) 1.16
Cytokine rescue of p53-dependent apoptosis and cell cycle arrest is mediated by distinct Jak kinase signaling pathways. Genes Dev (1998) 1.15
Insertion and truncation of c-myb by murine leukemia virus in a myeloid cell line derived from cultures of normal hematopoietic cells. J Virol (1987) 1.13
Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase. Hum Mol Genet (1994) 1.11
Are mandibular third molars a risk factor for angle fractures? A retrospective cohort study. J Oral Maxillofac Surg (1995) 1.11
Actively transcribed genes in the raf oncogene group, located on the X chromosome in mouse and human. Proc Natl Acad Sci U S A (1986) 1.09
E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis. Mol Cell Biol (1997) 1.09
Infection of Proplast malar implants and dental injections. Plast Reconstr Surg (1993) 1.08
Recombinant murine retroviruses containing avian v-myc induce a wide spectrum of neoplasms in newborn mice. Proc Natl Acad Sci U S A (1986) 1.08
c-Myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways. Oncogene (1996) 1.05
Mpl ligand prevents lethal myelosuppression by inhibiting p53-dependent apoptosis. Blood (2001) 1.02
E2F-1 and E2F-3 are functionally distinct in their ability to promote myeloid cell cycle progression and block granulocyte differentiation. Cell Growth Differ (1998) 1.02
Id2 promotes apoptosis by a novel mechanism independent of dimerization to basic helix-loop-helix factors. Mol Cell Biol (1998) 1.01
Risk factors for dental implant failure: a strategy for the analysis of clustered failure-time observations. J Dent Res (2002) 0.98
Macrophage growth arrest by cyclic AMP defines a distinct checkpoint in the mid-G1 stage of the cell cycle and overrides constitutive c-myc expression. Mol Cell Biol (1992) 0.96
Position and orientation independent transactivation by c-Myc. Cell Mol Biol Res (1994) 0.95
Occupational blood exposure and HIV infection among oral and maxillofacial surgeons. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1998) 0.95
Effects of anti-proliferative cyclic AMP on interleukin 2-stimulated gene expression. J Immunol (1987) 0.95
Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathways. Oncogene (1997) 0.94
Interleukin 3 (IL-3) induces transcription from nonrearranged T cell receptor gamma loci in IL-3-dependent cell lines. J Exp Med (1989) 0.94
Transformation of murine bone marrow cells with combined v-raf-v-myc oncogenes yields clonally related mature B cells and macrophages. Mol Cell Biol (1990) 0.94
Trends and differentials in mortality from cancers of the oral cavity and pharynx in the United States, 1973-1987. Cancer (1994) 0.93
Biochemical and molecular events associated with interleukin 2 regulation of lymphocyte proliferation. Immunol Rev (1986) 0.93
Frailty approach for the analysis of clustered failure time observations in dental research. J Dent Res (2005) 0.93
E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation. Oncogene (2001) 0.92
Jak3 selectively regulates Bax and Bcl-2 expression to promote T-cell development. Mol Cell Biol (2001) 0.92
Role of c-myc and other genes in interleukin 2 regulated CT6 T lymphocytes and their malignant variants. J Immunol (1987) 0.92
c-Myc-mediated regulation of telomerase activity is disabled in immortalized cells. J Biol Chem (2001) 0.91
Percutaneous injuries in dentistry: an observational study. J Am Dent Assoc (1995) 0.91
Hepatitis B vaccination and infection among U.S. dentists, 1983-1992 . J Am Dent Assoc (1996) 0.91
The polyamine oxidase inhibitor MDL-72,527 selectively induces apoptosis of transformed hematopoietic cells through lysosomotropic effects. Cancer Res (1999) 0.90
Nasopharyngeal carcinoma: clinical assessment and review of 176 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2001) 0.90
Risk factors associated with dental implants in healthy and medically compromised patients. Int J Oral Maxillofac Implants (1992) 0.90
Factors associated with hepatitis B vaccine response among dentists. J Dent Res (1994) 0.90
Epidemiologic review of facial infections in hospitalized pediatric patients. J Oral Maxillofac Surg (1994) 0.89
The role of ornithine decarboxylase in c-Myc-induced apoptosis. Curr Top Microbiol Immunol (1995) 0.88
Liquid crystal thermography as a diagnostic aid and objective monitor for TMJ dysfunction and myogenic facial pain. J Craniomandib Disord (1989) 0.88
Expression of tie receptor tyrosine kinase in leukemia cell lines. Leukemia (1993) 0.88
Risk factors for infection following operative treatment of mandibular fractures: a multivariate analysis. Plast Reconstr Surg (1993) 0.88
The association between water fluoridation and hip fracture among white women and men aged 65 years and older. A national ecologic study. Ann Epidemiol (1992) 0.88
A comparison of single-photon emission computed tomography and planar imaging for quantitative skeletal scintigraphy of the mandibular condyle. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1995) 0.87
c-myc transactivates the ornithine decarboxylase gene. Curr Top Microbiol Immunol (1992) 0.87
Cytokines suppress apoptosis independent of increases in reactive oxygen levels. J Immunol (1996) 0.87
Kaplan-Meier analysis of dental implant survival: a strategy for estimating survival with clustered observations. J Dent Res (2001) 0.86
Fas activates NF-kappaB and induces apoptosis in T-cell lines by signaling pathways distinct from those induced by TNF-alpha. Cell Death Differ (1997) 0.86
Head, neck, and facial injuries as markers of domestic violence in women. J Oral Maxillofac Surg (1999) 0.86
Predicting dental implant survival by use of the marginal approach of the semi-parametric survival methods for clustered observations. J Dent Res (2002) 0.85
v-Raf/v-Myc synergism in abrogation of IL-3 dependence: v-Raf suppresses apoptosis. Curr Top Microbiol Immunol (1992) 0.84
Oncogenes: clinical relevance. Haematol Blood Transfus (1987) 0.83
Ninety-one osteoporosis patients affected with bisphosphonate-related osteonecrosis of the jaw: a case series. Calcif Tissue Int (2013) 0.82
Transformation by raf and myc oncogenes. Princess Takamatsu Symp (1986) 0.82
Cancer. A radical approach to treatment. Nature (2000) 0.82